Member Info for JSB1989

The timelines for submission, approval and commercialisation are not far away at all now. Investors will be coming around to this with 2018 only days away and psychologically the key dates feel much closer. I am expecting an IMM style rerate starting in the next two to three months with this momentum building and can see the SP above 100p before the actual approval. GL and the team have done a brilliant job so far and I am confident they will deliver in 2018.

Brakes off now. Can't wait to leave this suppressed trading range. Now let's see some IMM style rise.

The unattractive girls in school almost always became the attractive lady though kelsbell. I'm feeling your frustration though myself, this must be just a matter of time before the re-rate though.

Let's hope we get on a run now!!

This looks like it's within 10% of the bottom before the sustained rise leading into the big news time of Q4 2018 - Q1 2019. I've had the wife giving me an ear full of why her savings are been eaten away every day so I'm hoping for the wind to change soon. GL and the team are super busy, he mentioned the new drug submission to the FDA is 100,000+ pages of documentation!! I don't think he needs to do anymore than to keep up the hard work and the rerate will take place in due course.

Today's late rise was encouraging to see. People are taking interest and with a new focus on the three licenses in Australia I expect to see this increasing in the coming weeks. With the lack of liquidity at the moment in the share I'm holding on to my 350000 tightly and good forward to the squeeze!

It's been very difficult to buy shares today. I bought 87000 this morning and tried this afternoon with no luck at first. I did three fill or kill orders at 1.5 which were rejected and then increase to 1.55 which was accepted giving me another 193000. I think this will blow through the roof with further interest following the restructure!!

Get your money out of the market and enjoy life

I think we will see an initial drop this morning before a recovery as similar to yesterday although not on the scale of a 10-15% swing. Investors will be fearful with the volatility yesterday and will sit on the sidelines until we see things stabilise.

Huge over reaction today! I expect to see some turbulence tomorrow and this to settle down next week with the start of steady rise back up to £15. The market clearly didn't like the FDA rejection of the Advair generic and the earnings warning back in May but this was priced in the drop then from £20 to £17. The share price has been walked down on the back of this for the last three months now and as the results show they are in line with estimates and have reduced their debt by £60 million. The valuation at £2.8billion is ridiculous and as of today our market cap is the same as Fevertree Drinks.